title: [The bone-marrow transplantation program in Hungary: report from the period 1990-1995].
abstract: The article summarises the statistical data of bone marrow transplantation (BMT) carried out in Hungary between 1990-1995 in yearly distribution. Since the first BMT up to the end of 1995, 168 BMT were performed. The number of transplantations since 1990 to our days was gradually increasing. As a result of this activity in the three transplantation centers (National Institute of Haematology and Immunology, St. László Hospital and County Hospital in Miskolc) 36 allogeneic and 12 autologous BMT were performed in 1995. Out of the allogeneic BMT cases, 14% of them were completed with unrelated, donors in the last three years. The most frequent indications for allogenic BMT are: chronic myeloid leukaemia (CML), acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplasia, severe aplastic anaemia. Child allogenic BMTs are carried out on pediatric patients in St. László Hospital in leukaemia, severe aplastic anaemia cases and children born with immunodeficiency. Autologous BMTs started in an organised way in 1995 for adult patients in cases of non-Hodgkin lymphoma, Hodgkin lymphoma and for children with solid tumour indication in the Miskolc Centre. BMT activity in Hungary compared with international data, especially within Europe, shows a significant drop behind. To calculate for ten million inhabitants, the optimal BMT activity should be between 100-200 transplantations (allogeneic and autologous BMT together) in 1994. Among the Central European countries Hungary and Poland fall most behind. Autologous BMTs in most countries of Europe are above of allogeneic BMTs in numbers as indication in cases of lymphoma and solid tumours (first of all mamma carcinoma) comes into focus. This summary emphasises the most important difficulties in connection with the development of the National BMT program.
authors.affiliation: Országos Hematológiai és Immunológiai Intézet Csontvelóátültetó és Immunterápiás Osztály.
authors.forename: G
authors.initials: G
authors.lastname: Petrányi
authors.forename: T
authors.initials: T
authors.lastname: Masszi
authors.forename: L
authors.initials: L
authors.lastname: Tímár
authors.forename: G
authors.initials: G
authors.lastname: Kriván
authors.forename: K
authors.initials: K
authors.lastname: Pálóczi
authors.forename: K
authors.initials: K
authors.lastname: Nagy
authors.forename: S
authors.initials: S
authors.lastname: Fekete
authors.forename: P
authors.initials: P
authors.lastname: Reményi
authors.forename: E
authors.initials: E
authors.lastname: Torbágyi
authors.forename: R
authors.initials: R
authors.lastname: Dénes
authors.forename: E
authors.initials: E
authors.lastname: Kelemen
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods / Q000706:statistics & numerical data*; D002648:Child; D005260:Female; D006801:Humans; D006814:Hungary; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous